Cranial nerve development

pathway activity — cross-omics
GO:0021545Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Cranial nerve development pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are GRAP2, CRTAM, and MS4A1, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Cranial nerve development activity versus GRAP2 in BRCA (Pearson r = -0.18).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAGRAP2 →-0.495-0.607.001.00234
BRCACRTAM →-0.611-0.809.001<.00134
BRCAMS4A1 →-1.144-0.699<.001<.00134
BRCAHTRA4 →-0.720-0.727<.001<.00134
UCECCCR4 →-0.574-0.285.004.00934
BRCATRGV2 →-0.535-0.585.001.00234
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0021545 vs GRAP2 — BRCA

Per-sample scatter of Cranial nerve development activity vs GRAP2 in BRCA.

Explore this scatter interactively →

Exploration